Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Nanoscale Res Lett ; 12(1): 115, 2017 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-28228000

RESUMEN

The therapeutic effect of pristine C60 fullerene aqueous colloid solution (C60FAS) on the functioning of the rat soleus muscle at ischemic injury depending on the time of the general pathogenesis of muscular system and method of administration C60FAS in vivo was investigated. It was found that intravenous administration of C60FAS is the optimal for correction of speed macroparameters of contraction for ischemic muscle damage. At the same time, intramuscular administration of C60FAS shows pronounced protective effect in movements associated with the generation of maximum force responses or prolonged contractions, which increase the muscle fatigue level. Analysis of content concentration of creatine phosphokinase and lactate dehydrogenase enzymes in the blood of experimental animals indicates directly that C60FAS may be a promising therapeutic agent for the prevention and correction of ischemic-damaged skeletal muscle function.

2.
Fiziol Zh (1994) ; 63(1): 77-83, 2017.
Artículo en Ucraniano | MEDLINE | ID: mdl-29975831

RESUMEN

The formation of connective tissue changes in the spinal canal of rats, caused by the method of intervertebral disc ruptures, in association with a mixture of epidural injection of longidaza and diprospan has been researched. Simultaneous injection of hialuronidase and betamethasone in composition of diprospan and longidaza, revealed a high synergistic effect and anti-fibrotic activity. Combined antifibrosis action of these two drugs is stronger than the sum of the actions of the two drugs in their separate use. Reducion of the maximum thickness of the fibrous layer was 49%, compared with the reference value and reduction of the total area of the fibrous formation was 46%. In our opinion, due to anti-inflammatory effects and the ability to reduce epidural scar adhesion, this complex is promising for its therapeutic use in treatment of spinal epidural fibrosis.


Asunto(s)
Antiinflamatorios/farmacología , Betametasona/análogos & derivados , Hialuronoglucosaminidasa/farmacología , Degeneración del Disco Intervertebral/tratamiento farmacológico , Desplazamiento del Disco Intervertebral/tratamiento farmacológico , Disco Intervertebral/efectos de los fármacos , Polímeros/farmacología , Rotura/tratamiento farmacológico , Animales , Betametasona/farmacología , Modelos Animales de Enfermedad , Combinación de Medicamentos , Sinergismo Farmacológico , Fibrosis/prevención & control , Disco Intervertebral/patología , Disco Intervertebral/fisiopatología , Degeneración del Disco Intervertebral/patología , Degeneración del Disco Intervertebral/fisiopatología , Desplazamiento del Disco Intervertebral/patología , Desplazamiento del Disco Intervertebral/fisiopatología , Ratas , Ratas Wistar , Rotura/patología , Rotura/fisiopatología , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA